IMUX

NASDAQStock

Immunic, Inc.

$1.19-0.18 (-13.50%)

52-Week Range

$0.51

$1.45

Key Stats

Market Cap

116.9M

P/E Ratio

—

Dividend Yield

—

Beta

1.48

Volume

4.8M

Avg Volume

3.6M

Performance

+57.45%

+123.24%

+77.19%

YTD

+134.99%

+19.13%

-16.46%

-91.61%

Price Chart

ETF Exposure

IMUX is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SURI	Simplify Propel Opportunities ETF	0.73%	398,932	$547K	$76.9M	2.82%
IWC	iShares Micro-Cap ETF	0.03%	257,028	$373K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	1,519,720	$950K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	126	$106	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,503	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	21	$18	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	2,563,855	$1.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	13,485	$11K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,162	$984	$1.29B	0.17%

About IMUX ETF Exposure

Immunic, Inc. (IMUX) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 116.9M, IMUX is a widely held institutional stock. The stock currently trades at $1.19. Investors can gain exposure to IMUX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMUX, sorted by portfolio weight.